Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT07003737. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies
ClinicalTrials.gov study NCT06532630. IPD Sharing: NO. Countries: 1. Publications: 0.
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT00556192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03610438. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00055146. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
ClinicalTrials.gov study NCT06375161. IPD Sharing: NO. Countries: 1. Publications: 0.
Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease
ClinicalTrials.gov study NCT00291681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
ClinicalTrials.gov study NCT06307600. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02456207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeting CD19/CD20/CD22 Triple-targeted Cell in Patients With Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05318963. IPD Sharing: NO. Countries: 1. Publications: 0.
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
ClinicalTrials.gov study NCT03853616. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT04271410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
ClinicalTrials.gov study NCT04775745. IPD Sharing: NO. Countries: 1. Publications: 0.
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL
ClinicalTrials.gov study NCT04781634. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
ClinicalTrials.gov study NCT03540303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
ClinicalTrials.gov study NCT04491370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy
ClinicalTrials.gov study NCT04870853. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT01686321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
ClinicalTrials.gov study NCT06479356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)
ClinicalTrials.gov study NCT03211702. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.